✨ Your Portfolio is fetched and updated from zerodha.
Nano Pharmaceuticals

Coral Laboratories Ltd.

CORALAB

Get real time AI alerts about this company on your WhatsApp!
Market Cap
₹162 Cr.
P/E
9.32

Coral Laboratories Ltd.

  • Coral Laboratories
  • Krebs Biochem.&Inds
  • Panchsheel Organics
  • TJI Pharma - Small Cap

FAQs on Coral Laboratories Ltd. Shareprice

Coral Laboratories has given better returns compared to its competitors.
Coral Laboratories has grown at ~13.2% over the last 3yrs while peers have grown at a median rate of -8.91%

Coral Laboratories is not expensive.
Latest PE of Coral Laboratories is 9.07, while 3 year average PE is 12.44.
Also latest EV/EBITDA of Coral Laboratories is 5.24 while 3yr average is 10.08.

View FAQ's On Business

Growth Table

  • Coral Laboratories Ltd.
  • Krebs Biochem.&Inds
  • Panchsheel Organics

Balance Sheet

  • Coral Laboratories Ltd.
  • Krebs Biochem.&Inds
  • Panchsheel Organics

Balance Sheet Snapshot

No data available.

Fund Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end

Profit & Loss

  • Coral Laboratories Ltd.
  • Krebs Biochem.&Inds
  • Panchsheel Organics

Cash Flow

  • Coral Laboratories Ltd.
  • Krebs Biochem.&Inds
  • Panchsheel Organics

Cash Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.

Ratios

= Dominant Factor
  • Coral Laboratories Ltd.
  • Krebs Biochem.&Inds
  • Panchsheel Organics

Quarterly Results

  • Coral Laboratories Ltd.
  • Krebs Biochem.&Inds
  • Panchsheel Organics

Reverse DCF

locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Raphson method.
Learn how to use Reverse DCF

FAQs on Coral Laboratories Ltd. Financials

Balance sheet of Coral Laboratories is strong.
It shouldn't have solvency or liquidity issues.

Yes, The net debt of Coral Laboratories is increasing.
Latest net debt of Coral Laboratories is -₹72.58 Crs as of Sep-25.
This is greater than Mar-25 when it was -₹155.99 Crs.

The profit is oscillating.
The profit of Coral Laboratories is ₹17.36 Crs for TTM, ₹24.16 Crs for Mar 2025 and ₹15.79 Crs for Mar 2024.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Coral Laboratories latest dividend payout ratio is 2.22% and 3yr average dividend payout ratio is 3.37%

Companies resources are allocated to majorly unproductive assets like Cash & Short Term Investments

View FAQ's On Shareholding
Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech